Welcome to the world of Micreos,...
Bacteria are an essential part of life on earth, but also a major cause of disease and death, affecting us all. Micreos develops phage-based products against specific dangerous bacteria and is viewed as product leader in this field. We focus on real solutions for human- and animal health, in food safety, and other areas where bacteria cause serious problems.
Every second day, half of the world's bacteria is destroyed by bacteriophages ('phages'). Different phages kill different bacteria. This bacterial specificity is at the same time a limitation of phages, and an advantage. Why? Because unlike antibiotics, phages cannot be used 'broad spectrum'. Nowadays this is viewed by many as a big advantage: only the unwanted bacteria are targeted, in other words, the desired bacteria that form part of our immune system, our food, etc, are left intact by phages, distinguishing phages from antibiotics. In the post-antibiotic era, phages present a simple and logical solution and will revolutionize the way we look at prevention and treatment of infections, and maintenance of healthy life on our planet.
Over a million people have benefited from phage technology targeted against all kinds of bacterial infections, including many antibiotic-resistant ones. Even more people are protected each day by phages against harmful pathogens in the food chain.
Micreos is committed to helping mankind with phage-based solutions which are effective, sustainable and affordable. The company's products:
- work fast
- are easy to apply
- have no side effects
Our head office is located in Wageningen, at the cross roads of the three Dutch 'Valleys', Health Valley, Food Valley and Agri Valley.
Micreos has a modern Phage Technology Centre, responsible for GMP-quality Production, Research & Development, and Quality Control. We work according to the highest ethical and professional standards, as witnessed by numerous awards and grants received over the past years, and publications in scientific journals and regular press. Micreos collaborates with top institutes and companies around the world and its advisors and partners have broad expertise in the fields in which we operate.
The company's product portfolio is rapidly expanding, with scheduled new product introductions by Micreos Human Health under the GLADSKIN™ brand against MRSA, Pseudomonas and acne, in 2012 and a new Micreos Food Safety product (SALMONELEX™), effective against Salmonella in the food chain, currently in large scale industrial trials.
LISTEX™, the company's product against the deadly Listeria monocytogenes (well known for its risk to pregnant women), is used globally by food processing companies. It is a culture of safe, natural phages, against Listeria in meat, cheese, fish, vegetables, fruit and other food products. LISTEX™ was the first phage product which was approved by the FDA as GRAS (Generally Recognised as Safe), in 2006, and by the USDA in 2007. Many other authorities have since confirmed its safety, including EFSA, Health Canada, BAG (Switzerland) and FSANZ (Food Standards Australia New Zealand).
Today, it helps many food processors in their fight against Listeria, without any effect on the properties of the treated food product. This means it leaves desired bacteria in place, i.e. in starter cultures for cheese production.
LISTEX™ was approved as processing aid for all food products by Health Canada in 2010 and by the USDA in 2011. It can be provided as 'OMRI-listed' or 'SKAL certified' (for use as processing aid in organic/EKO products). First customers in Europe and the US have been using the product daily to full satisfaction since 2006. Over the past years LISTEX™ has won many industry awards, including the FIE Gold Award, considered the 'Oscar' of the food industry.